Takeda T[au] - Search Results

Year	Number of Results
1953	1
1955	2
1956	2
1957	1
1958	1
1959	1
1961	10
1962	9
1963	10
1964	12
1965	13
1966	16
1967	8
1968	24
1969	13
1970	12
1971	5
1972	8
1973	10
1974	20
1975	14
1976	20
1977	11
1978	14
1979	15
1980	11
1981	26
1982	35
1983	35
1984	24
1985	43
1986	49
1987	56
1988	58
1989	81
1990	75
1991	67
1992	80
1993	93
1994	92
1995	101
1996	80
1997	63
1998	73
1999	78
2000	67
2001	79
2002	90
2003	80
2004	81
2005	78
2006	101
2007	92
2008	96
2009	106
2010	114
2011	83
2012	82
2013	80
2014	86
2015	89
2016	95
2017	101
2018	104
2019	110
2020	142
2021	171
2022	60

1

Retracted Note: Effects of Vitamin K2 on Osteoporosis.

Iwamoto J, Takeda T, Sato Y. Iwamoto J, et al. Among authors: takeda t. Curr Pharm Des. 2021;27(19):2325. doi: 10.2174/138161282719210608092930. Curr Pharm Des. 2021. PMID: 34264184

2

Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion.

Matsuda T, Irie T, Katsurabayashi S, Hayashi Y, Nagai T, Hamazaki N, Adefuin AMD, Miura F, Ito T, Kimura H, Shirahige K, Takeda T, Iwasaki K, Imamura T, Nakashima K. Matsuda T, et al. Among authors: takeda t. Neuron. 2019 Feb 6;101(3):472-485.e7. doi: 10.1016/j.neuron.2018.12.010. Epub 2019 Jan 9. Neuron. 2019. PMID: 30638745 Free article.

3

High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies.

Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, Takado Y, Shinotoh H, Sano Y, Yamamoto Y, Matsuoka K, Takuwa H, Shimojo M, Takahashi M, Kawamura K, Kikuchi T, Okada M, Akiyama H, Suzuki H, Onaya M, Takeda T, Arai K, Arai N, Araki N, Saito Y, Trojanowski JQ, Lee VMY, Mishra SK, Yamaguchi Y, Kimura Y, Ichise M, Tomita Y, Zhang MR, Suhara T, Shigeta M, Sahara N, Higuchi M, Shimada H. Tagai K, et al. Among authors: takeda t. Neuron. 2021 Jan 6;109(1):42-58.e8. doi: 10.1016/j.neuron.2020.09.042. Epub 2020 Oct 29. Neuron. 2021. PMID: 33125873 Free article.

4

Retraction Note: Forearm Bone Mineral Density in Postmenopausal Women with Rheumatoid Arthritis.

Iwamoto J, Takeda T, Ichimura S. Iwamoto J, et al. Among authors: takeda t. Calcif Tissue Int. 2020 Feb;106(2):218. doi: 10.1007/s00223-019-00631-z. Calcif Tissue Int. 2020. PMID: 31745586

5

Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer.

Morimoto K, Yamada T, Yokoi T, Kijima T, Goto Y, Nakao A, Hibino M, Takeda T, Yamaguchi H, Takumi C, Takeshita M, Chihara Y, Yamada T, Hiranuma O, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Takayama K. Morimoto K, et al. Among authors: takeda t. Lung Cancer. 2021 Nov;161:26-33. doi: 10.1016/j.lungcan.2021.08.015. Epub 2021 Aug 31. Lung Cancer. 2021. PMID: 34500218

6

Retraction Note: Urinary Cross-linked N-telopeptides of Type I Collagen Levels in Patients with Rheumatoid Arthritis.

Iwamoto J, Takeda T, Ichimura S. Iwamoto J, et al. Among authors: takeda t. Calcif Tissue Int. 2020 Feb;106(2):219. doi: 10.1007/s00223-019-00632-y. Calcif Tissue Int. 2020. PMID: 31745587

7

Retraction Note to: Effect of alendronate on bone mineral density and bone turnovermarkers in post-gastrectomy osteoporotic patients.

Iwamoto J, Uzawa M, Sato Y, Takeda T, Matsumoto H. Iwamoto J, et al. Among authors: takeda t. J Bone Miner Metab. 2021 May;39(3):521. doi: 10.1007/s00774-021-01209-2. J Bone Miner Metab. 2021. PMID: 33547942 No abstract available.

8

Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.

Iwamoto J, Takeda T, Sato Y, Uzawa M. Iwamoto J, et al. Among authors: takeda t. Clin Rheumatol. 2021 Aug;40(8):3385. doi: 10.1007/s10067-021-05788-3. Clin Rheumatol. 2021. PMID: 34143321 No abstract available.

9

Retraction Note: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.

Iwamoto J, Takeda T, Sato Y, Uzawa M. Iwamoto J, et al. Among authors: takeda t. Clin Rheumatol. 2021 Aug;40(8):3383. doi: 10.1007/s10067-021-05787-4. Clin Rheumatol. 2021. PMID: 34143320 No abstract available.

10

Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study.

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H. Iwamoto J, et al. Among authors: takeda t. Drugs Aging. 2019 Oct;36(10):979. doi: 10.1007/s40266-019-00702-8. Drugs Aging. 2019. PMID: 31418156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results